Caspase-1 inhibitor
This page covers all Caspase-1 inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Caspase-1.
Targets
Phase 3 pipeline (1)
- bIAP bolus and 8h infusion · Alloksys Life Sciences B.V. · Inflammatory diseases
bIAP is a caspase-1 inhibitor that blocks the activation of inflammatory caspases.